About KAHR medical

KAHR Medical is developing an innovative and novel drug platform of immunotherapeutic bi-functional fusion proteins that harness the human immune system to target multiple cancer indications.

Company Highlights
Year Founded

2005

icon-altEmployees

27

Location (HQ)

ISR

Since Last Funding

1 year 7 months

icon-altTotal Investment Amt

$89M

Last Funding Round

Series Unknown

icon-altYoY Headcount Growth

-9.97%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Biotechnology Research

Medical

Pharmaceutical